# Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases

> **NCT04723069** · PHASE2 · COMPLETED · sponsor: **University of Karachi** · enrollment: 198 (actual)

## Conditions studied

- Pelvic Inflammatory Disease

## Interventions

- **DRUG:** Control Group
- **DRUG:** Test Group

## Key facts

- **NCT ID:** NCT04723069
- **Lead sponsor:** University of Karachi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2022-03-11
- **Final completion:** 2022-03-11
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2023-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723069, "Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04723069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*